Centers for Disease Control and Prevention identifies First US cases of Drug-Resistant Fungal Infection

November 5, 2016: Thirteen individuals have become ill from a serious and fatal fungal infection previously unseen in the United States, the Centers for Disease Control and Prevention said on Friday.

The fungus, Candida auris, is known to occur in healthcare settings such as hospitals and nursing homes, CNN reported.

NewsGram brings to you current foreign news from all over the world

Seven cases occurred between May 2013 and August 2016 in four states: Illinois, Maryland, New Jersey and New York. As of August 31, four of these seven patients, all with bloodstream infections, died, though it is unclear whether their deaths were due to C. auris.

The remaining six cases were identified after August and are still under investigation.

"It appears that C. auris arrived in the United States only in the past few years," Dr. Tom Chiller, Chief of the CDC's Mycotic Diseases Branch, said in a statement.

NewsGram brings to you top news around the world today

He added that scientists are working to better understand the fungus so they can develop recommendations to protect those at risk.

C. auris bloodstream infections have a 50 percent fatality rate in some countries, according to one study.

Some strains of this yeast are multidrug-resistant and cannot be treated by the three major classes of antifungal medications.

First reported in 2009 in Japan, cases have been recorded in South Korea, India, South Africa, Kuwait, Colombia, Venezuela, Pakistan and the United Kingdom.

"Experience outside the United States suggests that C. auris has high potential to cause outbreaks in healthcare facilities," the CDC notes on its website.

Check out NewsGram for latest international news updates

Importantly, this deadly organism is difficult to identify using traditional laboratory biochemical methods. (IANS)